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Although swine are natural hosts for influenza A viruses, the porcine T-cell response to swine influenza A virus
(FLUAVsw) infection has been poorly characterized so far. We have studied Ki-67 expression and FLUAVsw-specific
production of IFN-γ, TNF-α and IL-2 in CD4+ and CD8β+ T cells isolated from piglets that had been intratracheally
infected with a H1N2 FLUAVsw isolate. IFN-γ+TNF-α+IL-2+ multifunctional CD4+ T cells were present in the blood of
all infected animals at one or two weeks after primary infection and their frequency increased in four out of six
animals after homologous secondary infection. These cells produced higher amounts of IFN-γ, TNF-α and IL-2 than
did CD4+ T cells that only produced a single cytokine. The vast majority of cytokine-producing CD4+ T cells expressed
CD8α, a marker associated with activation and memory formation in porcine CD4+ T cells. Analysis of CD27 expression
suggested that FLUAVsw-specific CD4+ T cells included both central memory and effector memory populations. Three
out of six animals showed a strong increase of Ki-67+perforin+ CD8β+ T cells in blood one week post infection. Blood-
derived FLUAVsw-specific CD8β+ T cells could be identified after an in vitro expansion phase and were multifunctional
in terms of CD107a expression and co-production of IFN-γ and TNF-α. These data show that multifunctional T cells are
generated in response to FLUAVsw infection of pigs, supporting the idea that T cells contribute to the efficient control
of infection.Introduction
Pigs are natural hosts for influenza A viruses and infec-
tions of humans with swine influenza A viruses
(FLUAVsw) have been reported [1]. Moreover, the pig is
considered as a “mixing vessel” i.e. a species where reas-
sortments between avian and mammalian influenza virus
strains can occur which may lead to the emergence of
novel pandemic strains in humans. For example, in the
2009 pandemic H1N1 virus, genes closely related to
swine North American and Eurasian H1N1 viruses were
identified [2]. The 2009 pandemic H1N1 virus was fre-
quently transmitted from farmers to pigs during the last
years, thereby reflecting the zoonotic potential of this* Correspondence: wilhelm.gerner@vetmeduni.ac.at
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unless otherwise stated.virus. As a consequence, this transmission established a
new lineage of pandemic viruses (pandemic H1N2) in
pigs via reassortment with circulating swine influenza vi-
ruses [3].
These observations, but also economic and animal
welfare issues of FLUAVsw infections in pig production
units, justify investigations on pig-FLUAVsw host-
pathogen interactions. Of note, FLUAVsw infections are
usually rapidly controlled by the porcine immune system
and an elimination of replicating virus from the respira-
tory tract within one week has been reported [4]. Neu-
tralizing antibodies appear in serum within seven days
post inoculation [4]. It is assumed that these antibodies
play a major role in control of infection, although a pro-
duction of IgA antibodies by B cells in the nasal mucosa
has also been reported [5].
The rapid control of FLUAVsw infections suggests that
also cell-mediated immune responses contribute to viralhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the role of influenza virus-specific CD4+ and CD8+ T
cells in mice and humans [6], their role has not been
studied in great detail in pigs. A FLUAVsw-specific pro-
liferation of lymphocytes isolated from blood has been
reported following infection of pigs with H3N2 and
H1N1 FLUAVsw strains [7-9]. One study demonstrated
the proliferation of blood-derived CD4+ and CD8+ T
cells following vaccination with a human pandemic
H1N1 vaccine [10]. Also, the presence of H1N1-specific
IFN-γ producing T cells in tracheobronchial lymph
nodes, spleen and nasal mucosa has been described [5].
More recently, increased frequencies of cytolytic T cells
(CTLs), CD4+CD8α+ T cells and regulatory T cells have
been reported in lung tissue and bronchoalveolar lavage
fluid of H1N1-infected pigs six days post infection [11].
However, none of these studies investigated the pheno-
type and functional properties of FLUAVsw-specific T
cells in detail. Taking into account the rapid clearance of
FLUAVsw infections, we hypothesized that highly differ-
entiated CD4+ and CD8β+ T cells with multiple effector
functions are involved in protective immune responses.
Accordingly, we performed a detailed phenotypic and
functional analysis of FLUAVsw-specific T cells occur-




Nine three-week-old crossbred piglets ([Landrace ×
Large White] × Pietrain) were derived from a conven-
tional breeding farm in Lower Austria and were kept in
a biosafety level 2 facility at the University of Veterinary
Medicine Vienna. Sows at the farm were free of
FLUAVsw-specific antibodies. This was tested by a com-
mercial ELISA (Ingezim Influenza A, 1.0.FLU.K3, Ingenasa,
Madrid, Spain) at regular intervals. All piglets were vacci-
nated against Mycoplasma hyopneumoniae (MycoFLEX®,
Boehringer Ingelheim, Ingelheim, Germany) and against
porcine circovirus type 2 (CircoFLEX®, Boehringer
Ingelheim) at three weeks of age. After arrival, the pig-
lets were divided into a control group (three animals)
and an infection group (six animals). Seronegativity for
antibodies against Influenza A was confirmed by the
Ingezim Influenza A, 1.0.FLU.K3 ELISA (Ingenasa) one
day before FLUAVsw infection (four weeks of age). Piglets
were infected twice at an interval of four weeks. Each
time, 10 mL of virus suspension containing the FLUAVsw
isolate A/swine/Kitzen/IDT6142/2007 (H1N2) with 107.25
TCID50/mL was administered intratracheally by the use
of a laryngoscope to anesthetized piglets (Narketan®:
Ketaminhydrochlorid 10 mg/kg body weight (BW),
Vetoquinol, Lure, France; Stresnil®: Azaperon 1.2 mg/kg
BW, Janssen Pharmaceutical, Beerse, Belgium). Controlanimals underwent the same procedure, but received
phosphate buffered saline (PBS) instead. Daily, clinical
examinations were carried out and recorded in a clin-
ical score. Additionally, rectal temperature and body
weight were measured daily and weekly, respectively.
Euthanasia of pigs was performed either two or five
weeks following the second infection. Piglets were anes-
thetized (Narketan®, Stresnil®), before T61® (T61®:
Embutramid, Mebezoniumiodid, Tetracainhydrochlorid,
1 mL/10 kg BW, MSD, Whitehouse Station, NJ, USA)
was administered. At necropsy, gross lung lesions were
documented and samples from all seven lung lobes
were fixed in 10% neutral buffered formalin. The sam-
ples were processed for 3 μm thick paraffin sections
and stained with hematoxylin and eosin. The slides
were examined for presence and quantity of the follow-
ing parameters: (1) septal infiltration with mononuclear
cells, (2) lobular atelectasis and interstitial fibrosis with
metaplasia of alveolar epithelium, (3) interstitial forma-
tion of lymphoid follicles and/or bronchus-associated
lymphoid tissue (BALT) hyperplasia.
The animal experiment was approved by the institu-
tional ethics committee, the Advisory Committee for
Animal Experiments (§12 of Law for Animal Experiments,
Tierversuchsgesetz – TVG) and the Federal Ministry for
Science and Research (reference number BMWF-68.205/
0180-II/3b/2011).
FLUAVsw/Kitzen/IDT6142/2007 (H1N2) was origin-
ally isolated from an influenza outbreak in a pig herd in
Saxony, Germany. It was isolated on primary porcine
thymus cells and thereafter passaged on embryonated
hen eggs (three passages) and on MDBK cells. The forth
passage on MDBK cells was used for the experiments.
The virulence of this passage of this strain had been
proved by intratracheal and aerosol infection trials in
pigs at IDT Biologika GmbH during the development of
a swine influenza vaccine (EMEA/V/C/153) prior to the
experiments reported here. The strain is able to induce
dyspnea and fever in pigs at infection doses of 108.55
TCID50 MDBK at intratracheal infection. The sequences
of hemagglutinin and neuraminidase are available from
NCBI GenBank, accession numbers GQ161145 and
GQ161146, respectively. This virus belongs to the
human-like H1N2 swine influenza A viruses (huH1N2)
which contain the hemagglutinin of H1N1 influenza A
viruses which circulated in the human population in the
1970s/1980s and the neuraminidase of swine human-like
H3N2 influenza A viruses isolated in the UK in the early
1990s [12].
Sample collection and isolation of peripheral blood
mononuclear cells (PBMCs)
Blood samples were taken weekly by puncturing the an-
terior vena cava or the jugular vein. Leukograms (total
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by using the hematology system ADVIA2120i (Siemens
Healthcare Diagnostics, Eschborn, Germany). Serum
samples were frozen at −20 °C for subsequent detection
of neutralizing antibodies. PBMCs were isolated from
heparinized blood by density gradient centrifugation
with lymphocyte separation medium (PAA Laboratories,
Pasching, Austria) as described elsewhere [13]. Isolated
PBMCs were either directly used for ex vivo multicolor
flow cytometry (FCM) and IFN-γ ELISpot assays or were
cryopreserved for later in vitro experiments.
Serum neutralization test
Neutralizing antibodies were analyzed via serum
neutralization tests as previously described [12]. Briefly, a
serial dilution of sera was prepared and mixed with one of
four different virus strains: A/sw/Bakum/1832/2000
(huH1N2), A/sw/Haselünne/IDT2617/2003 (avH1N1), A/
sw/Bakum/IDT1769/2003 (huH3N2) and A/Jena/VI5256/
2009 (panH1N1). Each strain was adjusted to 100 TCID50.
After incubation for 1 h at 37 °C, the virus-incubated sera
were added to MDBK cell monolayers in microtiterplates.
The medium of MDBK cell cultures was supplemented
with porcine trypsin (γ-irradiated, final concentration 4
BAEE units/mL medium; Sigma-Aldrich, Schnelldorf,
Germany) at the time of infection and again after 24 h.
After 48 h of incubation at 37 °C, cells were fixed with
acetone and investigated by indirect immunofluorescence,
followed by ND50 calculation.
Phenotypic analysis of PBMCs performed ex vivo
For phenotypic analysis of CD4+ and CD8β+ T cells,
freshly isolated PBMCs were suspended in PBS (without
Ca2+/Mg2+, PAA) and 10% (v/v) porcine plasma (in-
house preparation) and adjusted to 1 × 106 cells per
sample. Monoclonal antibodies (mAbs) and secondary
reagents used for cell surface staining are listed in
Table 1. For detection of intracellular perforin and
Ki-67, cells were fixed and permeabilized by in-house
prepared fixation and permeabilization buffers containing
saponin, as described previously [14]. Staining was per-
formed in 96-well microtiterplates and cells were incu-
bated for 20 min at 4 °C in the fridge. Free binding sites of
secondary antibodies were blocked with whole mouse IgG
molecules (2 μg per sample, Jackson ImmunoResearch,
West Grove, PA, USA) during an additional incubation
step prior to fixation and permeabilization.
ELISpot assays for IFN-γ production
96-well MultiScreen IP plates (Millipore, Billerica, MA,
USA) were coated with mouse anti-swine IFN-γ mAb
(clone pIFN-γ, Mabtech, Nacka Strand, Sweden) over-
night at 4 °C (100 μL/well; 10 μg/mL in PBS), washed
with PBS and subsequently blocked with cell culturemedium (RPMI 1640 with stable glutamine supple-
mented with 10% [v/v] fetal calf serum, 100 IU/mL peni-
cillin and 0.1 mg/mL streptomycin, all from PAA) for
one hour at 37 °C. Per well, 3 × 105 freshly isolated
PBMCs were incubated with the FLUAVsw infection
strain (multiplicity of infection, MOI 0.1) or mock for
24 h at 37 °C. Samples incubated in cell culture medium
served as additional negative control. Thereafter, plates
were washed and incubated with biotin-labeled mouse
anti-IFN-γ mAbs (clone PAN, Mabtech, 100 μL/well;
0.5 μg/mL in PBS) for one hour at room temperature.
This was followed by incubation with streptavidin-
alkaline phosphatase (1:2000 in PBS supplemented with
0.01% Tween20 and 0.1% BSA, Roche, Mannheim,
Germany) for one hour at room temperature and subse-
quent addition of 5-bromo-4-chloro-3-indolyl phos-
phate/nitro blue tetrazolium substrate (100 μL/well,
Sigma-Aldrich) according to manufacturer’s instructions.
After intense washing and drying of plates, spots were
analyzed with an AID ELISpot reader (AID, Straßberg,
Germany).
Intracellular cytokine staining
For intracellular staining of IFN-γ, TNF-α and IL-2 in
CD4+ and CD8β+ T cells, PBMCs were defrosted and
rested at 37 °C for eight hours (5 × 105 cells per well in
150 μL cell culture medium). Thereafter, FLUAVsw (in-
fection strain, MOI = 0.1) was added to microcultures
and left overnight for 18 h at 37 °C in a total volume of
200 μL. During the last four hours, Brefeldin A (BD
GolgiPlug™, BD Biosciences, San Jose, CA, USA) was
present in microcultures at a final concentration of
1 μg/mL. Mock- and medium-incubated cultures served
as controls. For subsequent FCM staining in microtiter-
plates, cells were washed in PBS (without Ca2+/Mg2+)
containing 3% (v/v) fetal calf serum and incubated with
antibodies and secondary reagents listed in Table 1.
Free binding sites of secondary antibodies were blocked
with whole mouse IgG molecules (details see above)
and Near-IR LIVE/DEAD stain kit (Life Technologies,
Carlsbad, CA, USA) was used according to manufac-
turer’s instructions. For fixation and permeabilization
of cells, BD Cytofix/Cytoperm and BD Perm/Wash
(both BD Biosciences) were used according to manufac-
turer’s instructions.
In vitro expansion and functional analysis of CD8β+ T cells
Defrosted PBMCs were labeled with CellTrace™ Violet
Cell Proliferation Kit (Life Technologies) as described
elsewhere [15]. Per well, 5 × 105 violet-stained PBMCs
were plated together with FLUAVsw (infection strain,
MOI 0.1) and were incubated at 37 °C for five days. At
the fifth day, cells were restimulated for a second time
with FLUAVsw (MOI 0.1) for another 18 h. Four hours
Table 1 Antibody panels
Antigen Clone Isotype Fluorochrome Labeling strategy Source of primary Ab
Ex vivo Ki-67/CD4+ T cells
CD3 PPT3 IgG1 PE secondary antibodya in house
CD4 74-12-4 IgG2b Alexa488 secondary antibodyb in house
CD8α 11/295/33 IgG2a PE-Cy7 secondary antibodyc in house
CD27 b30c7 IgG1 Alexa647 directly conjugatedd in house
CD45RC 3a56 IgG1 PerCP-Cy5.5 directly conjugatede in house
SLA-DR MSA3 IgG2a Qdot605 directly conjugated in housef
Ki-67 B56 IgG1 V450 directly conjugated BD Biosciences
Ex vivo Ki-67/CD8β+ T cells
CD3 PPT3 IgG1 PE secondary antibodya in house
CD8β PG164A IgG2a Alexa488 Zenon labeling kitg VMRD
CD27 b30c7 IgG1 Alexa647 directly conjugatedd in house
SLA-DR MSA3 IgG2a Qdot605 directly conjugated in housef
Perforin δ-G9 IgG2b PerCP-eFluor710 directly conjugated eBioscience
Ki-67 B56 IgG1 V450 directly conjugated BD Biosciences
Triple cytokine staining/CD4+ T cells
CD4 74-12-4 IgG2b Alexa488 secondary antibodyb in house
CD8α 11/295/33 IgG2a PE-Cy7 secondary antibodyc in house
CD27 b30c7 IgG1 BV421 biotin-streptavidinh in house
IFN-γ P2G10 IgG1 PE directly conjugated BD Biosciences
TNF-α MAb11 IgG1 BV605 directly conjugated BioLegend
IL-2 A150D3F1 IgG2a APC directly conjugatedi Life Technologies
Triple cytokine staining/CD8β+ T cells
CD3 BB23-8E6-8C8 IgG2a PE-Cy7 directly conjugated BD Biosciences
CD8β PG164A IgG2a Alexa488 Zenon labeling kitg VMRD
CD27 b30c7 IgG1 BV421 biotin-streptavidinh in house
IFN-γ P2G10 IgG1 PE directly conjugated BD Biosciences
TNF-α MAb11 IgG1 BV605 directly conjugated BioLegend
IL-2 A150D3F1 IgG2a APC directly conjugatedi Life Technologies
In vitro expanded CD8β+ T cells
CD4 74-12-4 IgG2b PerCP-Cy5.5 directly conjugated BD Biosciences
CD8β PG164A IgG2a Alexa488 secondary antibodyj VMRD
CD107a 4E9/11 IgG1 Alexa647 directly conjugated AbD Serotec
Pan-γδ PPT16 IgG2b PE-Cy7 biotin-streptavidink in house
IFN-γ P2G10 IgG1 PE directly conjugated BD Biosciences
TNF-α MAb11 IgG1 BV605 directly conjugated BioLegend
aGoat anti-Mouse IgG1-PE, Southern Biotech.
bGoat anti-Mouse IgG2b-Alexa488, Life Technologies.
cGoat anti-Mouse IgG2a-PE-Cy7, Southern Biotech.
dAlexa Fluor-647 Protein Labeling Kit, Life Technologies.
eLightning-Link™ PerCP-Cy5.5 Tandem Conjugation Kit, Innova Biosciences.
fCustom conjugation by Life Technologies.
gIgG2a-Alexa488 Zenon labeling kit, Life Technologies.
hStreptavidin-BV421, BioLegend.
iLightning-Link™ APC Conjugation Kit, Innova Biosciences.
jGoat anti-Mouse IgG2a-Alexa488, Life Technologies.
kStreptavidin-PE-Cy7, eBioscience.
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together with Brefeldin A (GolgiPlug™, BD Biosciences;
final concentration 1 μg/mL) and Monensin (GolgiStop™,
BD Biosciences; final concentration 1 μg/mL). Cell surface
labeling and intracellular cytokine staining was performed
with reagents listed in Table 1, under the conditions de-
scribed above.
FCM analysis
FCM measurements were performed using a FACS-
Canto™ II flow cytometer (BD Biosciences) equipped
with three lasers (405, 488 and 633 nm) and a High
Throughput Sampler. Compensation was calculated
automatically with single-stain samples. For analysis of
ex vivo Ki-67 expression, at least 1 × 105 lymphocytes
were collected. Between 5 × 105 and 1 × 106 lymphocytes
were recorded for detection of intracellular cytokines.
Gating strategies for identification of lymphocytes, doub-
let discrimination and exclusion of dead cells are shown
in Additional file 1. Data was processed by FACSDiva
software (Version 6.1.3; BD Biosciences) or FlowJo soft-
ware (Version 7.6.5; Tree Star, Ashland, OR, USA) and
transferred to Microsoft Excel (Office 2010; Microsoft,
Redmond, WA, USA) for further calculations and prep-
aration of graphs.
Swine leukocyte antigen haplotyping
Pigs were genotyped for their swine leukocyte antigen
(SLA) class I and II haplotypes by running low-
resolution PCR screening assays (PCR-SSP) on PBMC-
derived genomic DNA as previously described [16].
Results
Clinical signs and pathological findings following
FLUAVsw infection
Typically, influenza infection of pigs leads to a rapid on-
set of respiratory signs accompanied by fever and leth-
argy. To verify successful influenza infection and to
evaluate protection from reinfection, animals were mon-
itored daily for clinical signs of disease, including inspec-
tion, lung auscultation and measurement of rectal
temperature. A clinical score was used to specify quality
and severity of the observed signs. PBS-treated control
animals (animal #1 to #3) did not show any signs of ill-
ness throughout the entire study (Figure 1A, first col-
umn and data not shown). All infected animals showed
lethargy, fever (>40 °C, Additional file 2) and respiratory
signs, including nasal discharge, coughing, dyspnea and
abnormal lung auscultation, starting one day post intra-
tracheal administration of virus. Exemplary scores for
dyspnea and lung auscultation of all infected animals (#4
to #9) are displayed in Figure 1A. Severity and quality of
these lower respiratory tract signs were similar among
individuals, with the exception of animal #7, showingsevere dyspnea and pleural friction rub in lung ausculta-
tion for several days following infection. All animals re-
covered within 7 to 9 days and did neither show clinical
signs nor fever after the second infection. At necropsy,
six (#4, #6, #8) and nine (#5, #7, #9) weeks post primary
infection, the lungs of animals #4, #7, #8 and #9 showed
localized lobular atelectasis with fibrous retraction at the
edges of the cranial and middle lobes. Enlarged bron-
chial or mediastinal lymph nodes were found in animals
#5, #6, #7, #8 and #9. Animal #7 additionally showed se-
vere adhesive pleuritis and pericarditis. Animals #5 and
#6 were without macroscopic changes. Compared to
control animals, histopathology revealed increased peri-
bronchial and interstitial infiltration of mononuclear
cells in animals #4, #5, #8 and #9. Retracted lobules
showed atelectasis with interstitial fibrosis, metaplasia of
alveolar epithelium as well as hyperplastic bronchiolar
epithelium (Additional file 3). In animal #7, in addition
to increased mononuclear interstitial infiltration and
BALT hyperplasia, histopathology showed multifocal
purulent bronchopneumonia.
H1N2-neutralizing antibodies
Neutralizing antibodies are considered as a hallmark for
strain-specific immunity following influenza infection.
We analyzed H1N2-neutralizing antibodies in sera of in-
fected and non-infected animals on a weekly basis. As
displayed in Figure 1B, neutralizing antibodies were
present in all infected animals (#4 to #9) one week after
primary infection. Slightly higher titers were measured
two weeks after primary infection. A boost of neutraliz-
ing antibodies following the second infection could be
observed in animals #5, #6, #8 and #9. In all animals,
neutralizing antibodies were detectable until euthanasia,
6 and 9 weeks after primary infection. Control animals
(#1 to #3) were negative for neutralizing antibodies
against H1N2 and all animals were negative for neutral-
izing antibodies against selected H1N1, H3N2 and
panH1N1 strains throughout the study (data not
shown).
Ex vivo Ki-67 expression
Ki-67 expression analysis has been used in human im-
munological studies to detect and quantify the expan-
sion phase of T cells responding to vaccination against
smallpox [17], yellow fever [17,18], but also infection
with hantavirus [19] and H1N1 influenza A virus [20].
Similarly, we hypothesized that infection of pigs with
FLUAVsw may lead to increased frequencies of blood-
derived Ki-67+ T-cell subsets in the time course follow-
ing infection. Weekly, freshly isolated PBMCs were
stained for Ki-67 expression in combination with differ-
ent T-cell lineage and differentiation markers and ana-
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Figure 1 Clinical score and H1N2-neutralizing antibody titers. (A) From one week prior to the first infection until the end of the study either
six or nine weeks post primary infection, piglets were daily monitored for clinical signs of disease. Auscultation score (solid line; 0 = physiologic,
1 = low-grade intensified vesicular, 2 =middle-grade intensified vesicular, 3 = high-grade intensified vesicular, 4 = bronchial, 5 = wheezing, 6 = rales,
7 = friction rub) and dyspnea score (dashed line; 0 = no dyspnea, 1 = dyspnea on exertion, 2 = dyspnea at rest, 3 = severe dyspnea) are shown for the
three PBS-treated control animals (#1 to #3) and the six FLUAVsw-infected animals (#4 to #9). (B) Weekly collected serum samples were tested for
H1N2-neutralizing antibodies by serum neutralization tests. Titers are expressed as the reciprocal neutralizing dose 50 (ND50). Data of PBS-treated
(#1 to #3) and FLUAVsw-infected (#4 to #9) animals is shown in the time course following infections. (A and B) The background color in each diagram
indicates different time spans: pre-infection (white), post primary infection (light grey) and post secondary infection (dark grey).
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not show any phenotypic changes or any increase in
the absolute number of Ki-67 expressing cells follow-
ing infection (data not shown). CD8β+ T cells, which
represent porcine cytolytic T cells [21], were analyzed
for the expression of perforin and CD27. By gating on
CD27dim/-perforin+ and CD27highperforin− Ki-67+CD8β+
T cells, we distinguished perforin− and perforin+ CD8β+ T
cells (Figure 2A) and calculated absolute numbers in the
time course following infection (Figure 2B). In three ani-
mals (#6, #8 and #9) we could detect a marked increase of
Ki-67+CD8β+ T cells one week after primary infection
followed by a continuous decline in weeks 2 and 3. The
expansion and contraction was mainly attributable to per-
forin+Ki-67+CD8β+ T cells. This might indicate an
infection-related expansion of CD8β+ T cells in at least
three (#6, #8 and #9) out of six animals. However, follow-
ing the second infection, no increase of Ki-67+CD8β+ T
cells could be detected in these three animals, and only a
slight increase was found in animals #4 and #7.In parallel, we analyzed CD4+ T cells for FLUAVsw
infection-related changes in Ki-67 expression. Expression
of CD8α and CD27 were co-analyzed on Ki-67+CD4+ T
cells (Figure 2C). CD8α is expressed on activated and
memory CD4+ T cells in swine [22,23] and down-
regulation of CD27 has recently been described as a
means to identify effector memory cells within porcine
CD4+CD8α+ T cells [24]. By respective gates, Ki-67+CD4+
T cells were separated into naïve CD8α− cells and antigen-
experienced CD8α+ cells and, again, absolute numbers
were calculated in the time course following infection
(Figures 2C and D). In animals #6, #7 and #8, we observed
a slight increase of Ki-67+CD4+ T cells, one or two weeks
after primary infection, with the majority of proliferating
cells expressing the activation marker CD8α. Following
the second infection, an increase of Ki-67+CD4+ T cells
could be detected in animals #4, #6 and #7. However,
overall, no substantial increase, as seen for CD8β+ T cells
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Figure 2 Kinetics of Ki-67+CD8β+ and Ki-67+CD4+ T cells in peripheral blood of FLUAVsw-infected pigs. Freshly isolated PBMCs were
stained and analyzed for CD4, CD8α, CD8β, CD27, Ki-67 and perforin expression by FCM. (A) CD3+CD8β+ T cells were gated for Ki-67 expression
and Ki-67+ cells were further analyzed for expression of CD27 and perforin. Perforin+ (red gate) and perforin− (grey gate) Ki-67+CD3+CD8β+ T cells were
further subgated for quantitative analysis over the time course following infection. (C) CD3+CD4+ T cells were gated for Ki-67 expression and Ki-67+
cells were further analyzed for CD8α and CD27 expression. CD8α+ (red gate) and CD8α− (grey gate) Ki-67+CD3+CD4+ T cells were subgated for quantitative
analysis over the time course following infection. (A and C) Exemplary raw data of animals #6 and #8, prior to infection and one week post infection, is
shown. (B and D) Absolute numbers of Ki-67-expressing subsets within CD8β+ T cells (B) and CD4+ T cells (D) of six infected animals in the
time course following infection. For calculation of absolute numbers, total lymphocyte counts were multiplied by percent values obtained by
gating on the respective T-cell subpopulation.
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Ex vivo Ki-67 expression kinetics of PBMCs pointed to-
wards increased proliferative activity of T cells following
FLUAVsw infection, but the specificity of this response
remains uncertain. As a first approach to identify
FLUAVsw-specific lymphocyte responses within PBMCs,
we measured IFN-γ production in ELISpot assays fol-
lowing in vitro restimulation with homologous virus. As
displayed in Figure 3, background levels of around 40
IFN-γ producing cells per 3 × 105 PBMCs were found in
microcultures stimulated with mock supernatants or cell
culture medium at all investigated time points (dark grey
and light grey lines). Similar levels were found in virus-
stimulated microcultures with PBMCs from non-infected
control animals. Within PBMCs of all six infected animals,
FLUAVsw-specific IFN-γ-producing cells could be de-
tected already one week after primary infection (Figure 3,
red lines). The magnitude of the IFN-γ response differed
between individuals, with animal #9 having up to four
times as many IFN-γ producing cells per 3 × 105 PBMCs
as compared with the other animals. This difference was
especially pronounced in week 1 after primary infectionweeks post prima
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Figure 3 Kinetics of FLUAVsw-specific IFN-γ-producing T cells identified by
isolated PBMCs were in vitro restimulated for 24 h with FLUAVsw (infection st
controls. Frequency of IFN-γ-producing cells within 3 × 105 PBMCs is displayed
(light grey line) cultures. Neutralizing antibody titers are displayed in dashed g
Figure 1B). Data of PBS-treated (#1 to #3) and FLUAVsw infected (#4 to #9) anand in week 5, when animal #9 showed a clear booster re-
sponse following the second infection. Booster responses
were also found in PBMCs of animals #6 and #8. For an
immediate comparison of the IFN-γ response in ELISpot
assays and the neutralizing antibody titers, the trajectory
curves of Figure 1B have been plotted into Figure 3. Over-
all, some synchronicity between the frequency of IFN-γ
producing cells and antibody titers could be observed
(animals #4, #6, #8 and #9), although there were opposing
courses at certain periods or time points.
IFN-γ, TNF-α and IL-2 production by CD4+ T cells
As IFN-γ ELISpots indicated the presence of FLUAVsw-
specific lymphocytes within PBMCs of infected animals,
the next step was to assign a phenotype to these
responding cells. On top, we aimed to identify potential
multifunctional FLUAVsw-specific T cells, as the simul-
taneous production of different cytokines or effector
molecules on the single T-cell level is proposed to be a
hallmark of protective immune responses [25]. Accord-
ingly, we performed intracellular cytokine staining for
IFN-γ, TNF-α and IL-2 in CD4+ and CD8β+ T cellsry infection
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ELISpot and H1N2-neutralizing antibody titers. For IFN-γ ELISpot, freshly
rain; MOI = 0.1). Mock- and medium-incubated cultures served as negative
for FLUAVsw- (red line), mock- (dark grey line) and medium-incubated
rey lines according to the secondary y-axis (for details see caption of
imals is shown in the time course following infections.
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displayed in Figure 4A and Additional file 4, within CD4+
T cells, double-cytokine-producing cells were virtually
absent prior to infection, but could be identified from
week 2 after primary infection onwards. Boolean gating
was used to quantify single-, double- and triple-cytokine-
producing CD4+ T cells in the time course following infec-
tion, as displayed in Figure 4B. A detailed analysis of the
frequency of CD4+ T cells producing a particular single
cytokine or cytokine combination is shown in Additional
file 5. Overall, FLUAVsw-specific cytokine+CD4+ T cells
were found to be increased from one (#7, #8) or two (all
other animals) weeks after primary infection. Double- and
triple-cytokine-producing cells started to be detectable at
two weeks after primary infection. In animal #9, we
observed a massive increase in the frequency of cytokine+
CD4+ T cells at one week post secondary infection (i.e.
five weeks after primary infection). This increase was
attributable mainly to IFN-γ single-producing and IFN-γ/
TNF-α double-producing CD4+ T cells (Additional file 5).
Apart from animal #9, an increase of cytokine+CD4+ T cells
following the second infection could be detected in animals
#6, #7 and #8. Single-cytokine-producing CD4+ T cells
produced mainly IFN-γ or TNF-α. Double-cytokine-
producing CD4+ T cells predominantly produced IFN-γ
in combination with TNF-α (Additional file 5).
Studies in humans and mice have shown that
multiple-cytokine-producing T cells produce more cyto-
kines on a per-cell basis compared to single-cytokine
producers [26-28]. By comparing the median fluores-
cence intensity (MFI) obtained by FCM for the investi-
gated cytokines (IFN-γ, TNF-α, IL-2) among single-,
double- and triple-cytokine-producing CD4+ T cells iso-
lated from week 2 after primary infection onwards, we
found higher quantities of IFN-γ and TNF-α in triple-
and double-producers (Figures 5A and B and Additional
file 6). IL-2 was slightly increased in triple-producers,
compared with single- and double-producers. Overall,
these findings might support the hypothesis that
multiple-cytokine-producing FLUAVsw-specific T cells
have a beneficial role in clearance of the infection.
Previous work of our group suggested that porcine
CD4+CD8α+ T cells can be differentiated upon their ex-
pression of CD27, with CD27+ and CD27− cells resem-
bling central memory (TCM) and effector memory T
helper cells (TEM), respectively [24]. Therefore, we inves-
tigated the seven different cytokine-producing subsets
identified by boolean gating for expression of CD8α and
CD27. As shown in Figure 5C and Additional file 7, the
vast majority of cytokine+CD4+ T cells expressed CD8α
(with some notable exceptions of TNF-α and IL-2
single-producing cells), thereby displaying the phenotype
of activated or antigen-experienced porcine CD4+ T
cells. However, within these CD4+CD8α+ T cells, theCD27 expression profile did not allow for a clear assignment
of responding cells to the CD27− TEM or the CD27
+ TCM sub-
set, as all seven cytokine-producing subsets were distributed
among both populations (Figure 5C and Additional file 7). In
summary, these data indicate that CD4+ T cells are in-
volved in the immune response to influenza infection in
pigs and that a considerable proportion of responding cells
is multifunctional in terms of IFN-γ, TNF-α and IL-2
production.
Proliferation, degranulation and cytokine production by
CD8β+ T cells
Having observed typical clinical signs of FLUAVsw infec-
tion, indicative of active viral replication in the upper and
lower respiratory tract, we expected to see a FLUAVsw-
specific activation of MHC-I-restricted CD8β+ T cells in
infected pigs. As shown above, analysis of ex vivo Ki-67
expression in peripheral blood CD8β+ T cells revealed ex-
pression dynamics reminiscent of an expansion and con-
traction phase of effector CD8β+ T cells in at least three
out of six animals. Using the overnight restimulation
protocol established for the intracellular cytokine staining
of CD4+ T cells (Figure 4), we detected very low frequen-
cies of FLUAVsw-specific cytokine-producing CD8β+ T
cells (Additional file 8). With the aim to increase the fre-
quency of FLUAVsw-specific CD8β+ T cells by in vitro ex-
pansion, we developed an alternative stimulation protocol,
consisting of a 6-day culture of PBMCs, with a first
FLUAVsw restimulation on day 0 and a second FLUAVsw
restimulation on day 5 of culture. This prolonged incuba-
tion time enabled us to additionally investigate prolifera-
tion in mock- and FLUAVsw-stimulated cultures by the
use of violet proliferation dye. Moreover, as hardly any
IL-2+CD8β+ T cells could be detected by the overnight re-
stimulation (Additional file 8), we decided to omit IL-2
and to analyze surface CD107a expression, indicative of
degranulation, instead. PBMCs isolated at two weeks
after primary infection, six weeks after primary infec-
tion (i.e. two weeks after secondary infection) and –
where available – nine weeks after primary infection
(i.e. five weeks after secondary infection) were ana-
lyzed. For each time point, intracellular IFN-γ and
TNF-α, surface CD107a expression and violet prolifera-
tion were analyzed. Exemplary contour plots displaying all
possible IFN-γ/TNF-α/CD107a/proliferation-marker com-
binations of gated CD8β+ T cells are shown for one con-
trol animal (#3) and one infected animal (#8) at six weeks
after primary infection (Figure 6A). CD8β+ T cells of non-
infected control animals showed some proliferation and de-
granulation, but hardly any cytokine production in re-
sponse to FLUAVsw or mock stimulation. Within CD8β+ T
cells of infected animals, cytokine production was detected
only in cells that had proliferated and all cytokine+



































































































1 2 3 5 6
1 2 3 5 6
7 8 91 2 3 5 6























Figure 4 Kinetics of FLUAVsw-specific IFN-γ-/TNF-α-/IL-2-producing CD4+ T cells. Intracellular cytokine staining of defrosted PBMCs was
performed following overnight in vitro restimulation with FLUAVsw (infection strain, MOI = 0.1; 18 h). Mock-incubated cultures served as negative
controls. (A) CD4+ T cells were gated and analyzed for production of IFN-γ, TNF-α and IL-2. Contour plots show combinations of cytokines for
selected time points following FLUAVsw infection. Exemplary data of animal #9 is shown. (B) Boolean gating was applied in order to identify
single-, double-, and triple-cytokine-producing CD4+ T cells. Single- (dark grey), double- (orange) and triple- (red) cytokine-producing cells are
shown as percent of total CD4+ T cells for all six infected animals in the time course following FLUAVsw infection.
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IFN- TNF- IL-2
Figure 5 IFN-γ/TNF-α/IL-2 expression levels and CD8α/CD27 expression of cytokine-producing CD4+ T cells. (A + B) Fluorescence intensity
of IFN-γ, TNF-α and IL-2 expression within single- (dark grey), double- (orange) and triple- (red) cytokine-producing CD4+ T cells. (A) Histograms show
exemplary data of animal #9 at six weeks post primary infection. Numbers indicate median fluorescence intensity (MFI) for each subset and the
respective cytokine. (B) MFI of IFN-γ, TNF-α and IL-2 expression within single- (dark grey), double- (orange) and triple- (red) cytokine-producing CD4+ T
cells isolated at six weeks post primary infection. Data of all six infected animals is shown by individual symbols. The mean is indicated by the black
bar. (C) CD8α and CD27 expression on total CD4+ T cells (contour plot in the upper left and light grey dots in dot plots) and CD4+ T cells producing a
single cytokine (dark grey dots, bottom), two cytokines (orange dots, middle) or three cytokines (red dots, top). Representative raw data of animal #9,
six weeks post primary infection, is shown.
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positive CD8β+ T cells were absent in mock-stimulated
cultures, but clearly detectable upon FLUAVsw restimula-
tion (Figure 6A, arrows). Having measured four different
functions of CD8β+ T cells simultaneously, we applied
boolean gating to identify and quantify all subsets, differ-
ing in the type and number of functions. From 11 possible
multifunctional subsets (i.e. ≥2 functions), three subsets
dominated strongly: proliferating CD107+ cells, (two func-
tions), proliferating CD107+IFN-γ+ cells (three functions)
and proliferating CD107+IFN-γ+TNF-α+ cells (four func-
tions; Additional file 9). Therefore, the subsets were clus-
tered according to the number of functions they exerted
(Figure 6B). Results are displayed as percent of multifunc-
tional cells within total CD8β+ T cells. Animals #6 and #8
showed the highest frequency of FLUAVsw-specific multi-
functional cells within CD8β+ T cells, isolated at six weeks
after primary infection, i.e. two weeks after secondary in-
fection. A lower frequency was detected in animals #7 and
#9 and no clear increase could be detected from the earli-
est to later time points. Hardly any virus-specific response
could be detected in CD8β+ T cells of animals #4 and #5,
similar to the non-infected control animals (#1, #3). Not-
ably, the lacking FLUAVsw-specific CD8β+-T-cell response
of animals #4 and #5 matched the results of the Ki-67 ex-
pression analysis (Figure 2B), as no expansion of Ki-67-
expressing CD8β+ T cells could be detected in these two
animals. In summary, these data indicate the presence of
FLUAVsw-specific multifunctional CD8β+ T cells within
PBMCs of four out of six animals.SLA haplotyping
T-cell responses are influenced by the binding properties
of particular major histocompatibility complex mole-
cules that mediate the presentation of peptides to the T-
cell receptor. To identify potential associations between
the T-cell response and the SLA haplotype, a low-
resolution SLA typing of the nine pigs included in the
present study was performed and revealed a total of nine
class I and eight class II haplotypes (Table 2). The most
common class I haplotypes were Lr-01.0 (#4, #6, #7, #9)
and Lr-24.0 (#3, #5, #6, #7), followed by Lr-25.0 (#1, #4)
and Lr-59.0 (#2, #3). Unique class I haplotypes were Lr-
45.0 (#1), Lr-08.0 (#2), Lr-18.0 (#5), Lr-40.0 (#8) and Lr-
46.0 (#8). Within class II, the most frequent haplotype
was Lr-0.15b (#2, #3, #4, #5, #6, #7), followed by Lr-0.09
(#3, #5, #6, #7) and Lr-0.25 (#1, #2, #4). Unique class
II haplotypes were found in pig #1 (Lr-0.22), pig #8
(Lr-0.10/Lr-0.23) and pig #9 (Lr-0.33/Lr-0.35).
Discussion
In the present study, we aimed to investigate the kinetics
and functional properties of FLUAVsw-specific CD4+
and CD8β+ T cells in the blood of FLUAVsw-infected
pigs. We also decided to perform a homologous reinfec-
tion four weeks after the primary infection in order to
monitor a potential expansion or change in functional
attributes of FLUAVsw-specific memory T cells under
such conditions. A FLUAVsw H1N2 isolate from Germany
was used for infection and in vitro restimulation. H1N2

























































































































Figure 6 Proliferation, degranulation and cytokine production by FLUAVsw-specific CD8β+ T cells. Violet-labeled PBMCs isolated at 2, 6
and 9 weeks post primary infection were restimulated twice with FLUAVsw (infection strain, MOI = 0.1; day 0 and day 5 of culture) and analyzed
by FCM on day 6 of culture. (A) CD8β+ T cells were gated (not shown) and analyzed for violet proliferation, surface CD107a expression and intracellular
accumulation of IFN-γ and TNF-α. Contour plots show all possible marker combinations. Exemplary raw data of one non-infected control animal (#3)
and one infected animal (#8) is shown for week 6 post primary infection. (B) Boolean gating was applied in order to identify multifunctional CD8β+ T
cells, and resulting CD8β+ T-cell subsets were grouped by number of functions. Displayed is the frequency of CD8β+ T cells carrying out two or more
functions within total CD8β+ T cells. Data of six FLUAVsw-infected animals (#4-9) and two non-infected control animals (#1, #3) is shown.
Talker et al. Veterinary Research  (2015) 46:52 Page 12 of 16herds since the 1990s [4]; therefore our infection model
should at least partially reflect field conditions.
To verify successful experimental infection with the
intratracheally administered H1N2 isolate, clinical signs
and post-mortem histopathological changes were exam-
ined. All infected animals developed clinical signs with
fever, lethargy and lower-respiratory-tract signs, which
have been described as the typical outcome of acute in-
fluenza infection [4,29]. Within one week, all animals re-
covered, which is consistent with the reported clearance
of influenza virus from the porcine lung within sevendays [4]. Clinical signs were absent from all animals
upon reinfection with the same strain four weeks later.
This is in accordance with previous studies, where pigs
underwent a homologous reinfection [5,7,30,31]. Macro-
scopic lesions were either mild, and confined to localized
lobular retractions at the edges of the cranial lobes, or
were even absent. Microscopically, we observed mild to
moderate infiltration of the lung tissue with mono-
nuclear cells and lobular atelectasis with fibrous retrac-
tion as well as metaplastic and hyperplastic changes of
the airway epithelium. These lesions were considered as
Table 2 Swine leukocyte antigen (SLA) haplotypes of pigs used in this study
SLA allele specificity SLA allele specificity
Pig # SLA class I haplotype SLA-1 SLA-3 SLA-2 SLA class II haplotype SLA-DRB1 SLA-DQB1 SLA-DQA
1
Lr-25.0 11XX 03XX 07XX Lr-0.22 06XX 02XX(0204) 02XX
Lr-45.0 08XX + cs02 07XX w08XX + 10XX Lr-0.25 13XX 09XX 04XX
2
Lr-08.0 04XX 03XX 07XX Lr-0.15b 04XX 02XX 02XX
Lr-59.0 11XX(1103) 05XX jh02 Lr-0.25 13XX 09XX 04XX
3
Lr-24.0 blank 04XX/hb06 02XX Lr-0.09 02XX 04XX 03XX
Lr-59.0 11XX(1103) 05XX jh02 Lr-0.15b 04XX 02XX 02XX
4
Lr-01.0 01XX 01XX 01XX Lr-0.15b 04XX 02XX 02XX
Lr-25.0 11XX 03XX 07XX Lr-0.25 13XX 09XX 04XX
5
Lr-18.0 04XX 03XX 01XX Lr-0.09 02XX 04XX 03XX
Lr-24.0 blank 04XX/hb06 02XX Lr-0.15b 04XX 02XX 02XX
6
Lr-01.0 01XX 01XX 01XX Lr-0.09 02XX 04XX 03XX
Lr-24.0 blank 04XX/hb06 02XX Lr-0.15b 04XX 02XX 02XX
7
Lr-01.0 01XX 01XX 01XX Lr-0.09 02XX 04XX 03XX
Lr-24.0 blank 04XX/hb06 02XX Lr-0.15b 04XX 02XX 02XX
8
Lr-40.0 16XX 05XX 10XX Lr-0.10 04XX 08XX 03XX
Lr-46.0 12XX 04XX/hb06 06XX Lr-0.23 10XX/er01 06XX/zs12 01XX
9
Lr-01.0 01XX 01XX 01XX Lr-0.33 11XX 02XX 02XX
Lr-01.0 01XX 01XX 01XX Lr-0.35 01XX 04XX 02XX
Talker et al. Veterinary Research  (2015) 46:52 Page 13 of 16signs of late-stage influenza infection. The microscopic le-
sions observed in animal #7 resembled alterations present
in intercurrent bacterial infections (such as Mycoplasma
spp., Pasteurella multocida or Haemophilus parasuis) and
were not representative for the infection group.
H1N2-neutralizing antibodies were detected at consid-
erable levels already one week after infection, confirming
the postulated relevance of the humoral response in the
clearance of FLUAVsw infections. With the exception of
animal #9, a clear boost in antibody titers was not ob-
served, which is consistent with a study reporting the lack
of a HI-titer increase after homologous reinfection [5].
As a first attempt to analyze the role of T cells in the
control of FLUAVsw infection, we looked for expansion
of CD4 and CD8β effector T cells via analysis of Ki-67
expression. In parallel, we followed the frequency of
FLUAVsw-specific multiple-cytokine-producing T cells.
The analysis of Ki-67+ T cells has been successfully used
in immunological studies addressing T-cell expansion in
response to influenza A virus infections within PBMCs
isolated from humans [20] and nonhuman primates [32].
In our study, we could identify a clear expansion of
CD8β+Ki-67+perforin+ T cells at one week after primary
infection in three out of six animals. This heterogeneity
is somewhat similar to results obtained by a study of hu-
man T cells [20], where, seven days after infection, a
strong variation in the frequency of CD4+CD38+Ki-67+
and CD8+CD38+Ki-67+ T cells was observed betweendifferent individuals. In contrast, a more homogenous
response in regard to expansion of blood-derived
CD8+CD38+Ki-67+ T cells has been reported for H1N1-
infected rhesus macaques [32]. The reasons for the lack of
a CD8β+-T-cell expansion in the blood of at least two in-
fected pigs (#4, #5) are speculative. Interestingly, these
two animals also lacked a response of CD8β+ T cells in the
in vitro restimulation experiments addressing FLUAVsw-
specific proliferation, cytokine production and CD107a
expression (Figure 6B). These findings may suggest that a
CTL response was only weakly triggered in these two ani-
mals. Clearly, a parallel analysis of the T-cell response
present in the lung will lead to a more comprehensive
overview of the cell-mediated response and its variation
among individual pigs.
The lack of a substantial FLUAVsw infection-related ex-
pansion of CD4+ T cells (in all animals) might be also due to
a masking by T-cell responses to other environmental an-
tigens encountered following weaning, and by T-cell re-
sponses to the vaccines (porcine circovirus type 2,
Mycoplasma hyopneumoniae, see chapter 2.1) administered
at three weeks of age. Indeed, in a previous study from our
group we could show that, following weaning at three weeks
of age, a considerable increase of CD4+ T cells with an ac-
tivated and/or memory phenotype occurs in blood [23].
These observations also provide some evidence that,
despite the relatively young age of the piglets in this study
at the time of the first infection (i.e. four weeks), CD4+ T
Talker et al. Veterinary Research  (2015) 46:52 Page 14 of 16cells were already capable to respond to the FLUAVsw in-
fection. Similarly, the observed expansion of CD8β+ T cells
in the blood of three animals following FLUAVsw infection
might indicate that also this T-cell subset was already in a
maturation stage enabling a reaction to this viral infection.
Multifunctional T cells have been proposed as a hall-
mark of protective immunity [18,26,27,33,34]. Perform-
ing triple-cytokine staining of in vitro restimulated
PBMCs, we found that a considerable proportion of
FLUAVsw-specific CD4+ T cells can be activated to pro-
duce two or three of the cytokines IFN-γ, TNF-α and IL-
2 simultaneously. Triple-cytokine-producing CD4+ T
cells were detectable in the blood of all infected pigs
from two weeks post primary infection onwards. This
rather late appearance in regard to the clearance of clin-
ical signs questions their immediate role in the primary
immune response against FLUAVsw, but may indicate
relevance in the formation of memory T cells. Also, an in-
crease of single-, double- and triple-cytokine-producing
CD4+ T cells was observed in four (#6, #7, #8, #9) out of
six animals after the secondary infection, supporting the
assumption that multifunctional CD4+ T cells are a part of
the FLUAVsw-specific memory-T-cell pool.
CD4+ multifunctional T cells produced more IFN-γ,
TNF-α and IL-2 on a per-cell level, and triple producers
outranked double-producers, especially in the produc-
tion of IFN-γ (Figures 5A and B and Additional file 6).
This confirms an observation already made for murine
[26,28] and human T cells [27,34,35]. For CD8β+ T cells,
IL-2 production was undetectable in the overnight re-
stimulated cultures (Additional file 8). Interestingly, re-
cent work from our laboratory showed that, even after
polyclonal stimulation, CD8β+ T cells isolated from por-
cine blood produce hardly any IL-2, whereas such T cells
can be readily identified in bronchial lymph nodes [36].
This might indicate a rapid homing of IL-2-producing
CD8β+ T cells into lymphatic organs. Of note, human
influenza-specific CD8+ T cells were shown to produce
IL-2 upon influenza A virus restimulation, but protec-
tion from severe illness was found to correlate only with
preexisting IFN-γ+CD8+ T cells and no correlation was
found for IL-2-producing CD8+ T-cell subsets [37].
Generally, cytokine production of CD4+ T cells was
mostly associated with CD8α expression, which is de-
scribed as a marker to distinguish naïve from antigen-
experienced CD4+ T cells in swine [22,23]. Cytokine
combinations including IFN-γ appeared to be even more
restricted to CD8α expression, which is in accordance
with the description of IFN-γ being a signature cytokine
of late-differentiated human T cells [38]. For CD27 ex-
pression, which was proposed to distinguish between ef-
fector and central memory CD4+ T cells in swine [24],
we could not find any cytokine-related patterns. Both,
the putative CD8α+CD27+ central memory subset andthe putative CD8α+CD27− effector memory subset con-
tained FLUAVsw-specific cytokine-producing T cells, in-
dicating that both T-cell subsets contribute to the
FLUAVsw-specific memory-T-cell pool in pigs.
A reliable frequency of FLUAVsw-specific CD8β+ T
cells could only be identified after a six-day in vitro expan-
sion. These responding CD8β+ T cells consisted mainly of
IFN-γ/TNF-α-double-producing cells (Figure 6A, arrows).
A dominant co-production of IFN-γ and TNF-α was also
shown for human CD8+ T cells responding to influenza
peptide restimulation [39]. This co-production of the anti-
viral cytokines IFN-γ and TNF-α is described as the pre-
dominant functional signature of effector CD8+ T cells in
humans [38].
Similar to the variable frequencies of FLUAVsw-specific
cytokine-producing CD4+ T cells, we found considerable
variation in magnitude and kinetics of FLUAVsw-specific
cytokine-producing CD8β+ T cells among individual pigs
(Figure 6B). Strong variations of the CD8+-T-cell response
were also described for outbred mice following bacterial
or viral infection [40]. In humans, a recent study of
CD8+-T-cell immunity across ethnicities highlighted
the influence of different human leukocyte antigen class
1 haplotypes on the resulting individual differences in
magnitude and quality of influenza-specific CD8+ mem-
ory T cells [39]. Interestingly, the low-resolution swine
leukocyte antigen (SLA) typing of the pigs used in our
study revealed that pig #9, which showed a strong ex-
pansion of Ki-67+CD8β+ T cells and the highest fre-
quencies of FLUAVsw-specific cytokine-producing CD4
+ T cells, had a homozygous SLA class I haplotype and
was also homozygous for the SLA-DQA locus (Table 2).
However, the SLA class I haplotype of animal #9 was
also present in the CD8β+-T-cell-non-responding pig
#4, indicating that further factors or minor differences
in the SLA class I haplotypes, only identifiable by high-
resolution SLA typing, are responsible for the observed
differences in the CD8β+-T-cell response.
In conclusion, our data demonstrate the generation of
FLUAVsw-specific CD4+ and CD8β+ T cells in the im-
mune response to influenza A virus infection in the pig.
The observed multifunctional profile of FLUAVsw-
specific T cells suggests a function in protective immun-
ity, similar to the relevance of multifunctional T cells in
the control of viral infections in humans [25]. Clearly,
this has to be addressed in heterologous reinfection
studies, which will provide important insights into T-cell-
mediated cross-protection. Of note, the T-cell responses
described in this study were analyzed in blood, i.e. on a
systemic level. In future studies it is necessary to analyze
FLUAVsw-specific T cells also on the local level in the
lung, as FLUAVsw infections do not cause viremia [4] and
therefore represent a local infection. Work on this is in
progress in our laboratory, indicating a strong enrichment
Talker et al. Veterinary Research  (2015) 46:52 Page 15 of 16of FLUAVsw-specific CD8β+ T cells in the porcine lung
(S.C. Talker and W. Gerner, unpublished data). Such an
in-depth characterization of the porcine T-cell response to
influenza infection will contribute to the development of
improved vaccines for pig husbandry. These novel vac-
cines should also reduce viral transmission between swine
and humans, a risk factor associated with the emergence
of – potentially pandemic – reassortant influenza strains.Additional files
Additional file 1: FCM gating strategy used for freshly isolated
PBMCs (A) and for defrosted, in vitro restimulated PBMCs (B). (A + B)
Lymphocytes were gated according to FSC-A/SSC-A characteristics.
Consecutive FSC-H/FSC-W and SSC-H/SSC-W plots were used to gate on
singlets. (B) For analyses with defrosted and in vitro restimulated PBMCs,
dead cells were excluded by the use of the LIVE/DEAD stain Near-IR.
Additional file 2: Rectal temperatures in the time course. Rectal
temperatures were recorded daily from one week prior to infection until
the end of the study, i.e. 6 weeks or 9 weeks post primary infection. Mean
values and standard deviations for the PBS-treated control pigs (grey line)
and the H1N2-infected pigs (red line) are shown in the time course. Asterisks
at one and two days post primary infection indicate significant differences
between the infected and the control group (p≤ 0.001, unpaired t-test,
SPSS Inc./ IBM, Chicago, IL, USA, Version 19).
Additional file 3: Representative macroscopic and histologic lesions
in a FLUAVsw-infected pig (#4) in comparison to a control animal
(#2). The control animal shows no macroscopic alterations at the edges
of the right cranial and middle lung lobes (A). Histologically, the lung
tissue of the control animal shows thin alveolar walls and no inflammatory
cells in the alveolar spaces and alveolar septa (C). The bronchioles are lined
by a cuboidal epithelium and there are few mononuclear cells in the
surrounding interstitium (E). In the infected animal there are several
consolidated and retracted lobules at the ventral edge of the cranial
and middle lobe (B). Microscopically, there is diffuse infiltration with
mononuclear cells, fibrosis and metaplastic transformation of alveolar
epithelia to cuboidal formations (D). Bronchiolar epithelia are markedly
hyperplastic with pseudostratified columnar appearance and the
surrounding interstitium is infiltrated with numerous mononuclear cells
(F). Bars: 150 μm (C,D); 80 μm (E,F).
Additional file 4: Kinetics of FLUAVsw-specific IFN-γ-/TNF-α-/IL-2-
producing CD4+ T cells. Intracellular cytokine staining of defrosted
PBMCs was performed following overnight in vitro restimulation with
FLUAVsw (infection strain, MOI = 0.1; 18 h). Mock-incubated cultures
served as negative controls. CD4+ T cells were gated and analyzed for
production of IFN-γ, TNF-α and IL-2. Contour plots show combinations of
cytokines for selected time points following FLUAVsw infection. (A)
Exemplary data of animal #7 (intermediate response) and (B) animal #8
(low response) is shown.
Additional file 5: Kinetics of FLUAVsw-specific CD4+ T-cell subsets
producing different cytokines. Intracellular cytokine staining of
defrosted PBMCs was performed following overnight in vitro restimulation
with FLUAVsw (infection strain, MOI = 0.1; 18 h). Mock-incubated cultures
served as negative controls. CD4+ T cells were gated and analyzed for
production of IFN-γ, TNF-α and IL-2 as in Figure 4. Boolean gating was
applied in order to identify all seven subsets of cytokine-producing CD4+ T
cells. The frequency of the seven different cytokine-producing T-cell subsets
are shown in stacked bar charts as percent of total CD4+ T cells for all six
infected animals in the time course following FLUAVsw infection.
Additional file 6: IFN-γ/TNF-α/IL-2 expression levels of cytokine-
producing CD4+ T cells. (A + B) Fluorescence intensity of IFN-γ, TNF-α
and IL-2 expression within single- (dark grey), double- (orange) and
triple- (red) cytokine-producing CD4+ T cells. Histograms show data of
cells isolated from animal #7 (A; intermediate response) and animal #8
(B; low response) at six weeks post primary infection. Numbers indicatemedian fluorescence intensity (MFI) for each subset and the respective
cytokine. (C) MFI of IFN-γ, TNF-α and IL-2 expression within single- (dark grey),
double- (orange) and triple- (red) cytokine-producing CD4+ T cells isolated at
two to six weeks post primary infection. Data of all six infected animals is
shown by individual symbols. The mean is indicated by the black bar.
Additional file 7: CD8α/CD27 expression of cytokine-producing
CD4+ T cells. CD8α and CD27 expression on total CD4+ T cells (contour
plot in the upper left and light grey dots in dot plots) and CD4+ T cells
producing a single cytokine (dark grey dots, bottom), two cytokines
(orange dots, middle) or three cytokines (red dots, top). Data of CD4+
T cells from animal #7 (A; intermediate response) and animal #8 (B; low
response) at six weeks post primary infection is shown.
Additional file 8: Production of IFN-γ, TNF-α and IL-2 by FLUAVsw-
specific CD8β+ T cells. Intracellular cytokine staining of defrosted PBMCs
was performed following overnight in vitro restimulation with FLUAVsw
(infection strain, MOI = 0.1; 18 h). Mock-incubated cultures served as negative
controls. CD3+CD8β+ T cells were gated and analyzed for production of
IFN-γ, TNF-α and IL-2. Contour plots show combinations of cytokines for
selected time points following FLUAVsw infection. Exemplary data obtained
with CD8β+ T cells of animal #6 is shown.
Additional file 9: Multifunctional FLUAVsw-specific CD8β+ T cells
identified by proliferation, CD107a expression and cytokine
production. Violet-labeled PBMCs isolated at 2, 6 and 9 weeks post
primary infection were restimulated twice with FLUAVsw (infection strain,
MOI = 0.1; day 0 and day 5 of culture). On day 6 of culture, PBMCs were
analyzed by FCM for proliferation, CD107a expression and production
of IFN-γ and TNF-α. Boolean gating was applied in order to identify
multifunctional subsets of CD8β+ T cells. All 11 multifunctional subsets
(i.e. ≥ 2 functions) are shown in the left panel as stacked bar charts in %
of total CD8β+ T cells. In the right panel, the subsets are grouped according
to the number of functions they exert (as shown in Figure 6B). Data of six
FLUAVsw-infected animals (#4-9) and two non-infected control animals
(#1, #3) is shown.
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